EP1796610A4 - TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON DISEASE - Google Patents

TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON DISEASE

Info

Publication number: EP1796610A4
Authority: EP; European Patent Office
Prior art keywords: therapeutic system; transdermal therapeutic; parkinson disease; parkinson; disease
Prior art date: 2004-09-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP05802679A

Other languages

German (de)

French (fr)

Other versions

EP1796610A2 (en

Inventor

Marina Braun

Willi Cawello

Eric B Foster

Thomas Lauterbach

Hans-Michael Wolff

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

UCB Inc

Original Assignee

Schwarz Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-29

Filing date

2005-09-29

Publication date

2012-12-05

2005-09-29 Application filed by Schwarz Pharma Inc filed Critical Schwarz Pharma Inc

2007-06-20 Publication of EP1796610A2 publication Critical patent/EP1796610A2/en

2012-12-05 Publication of EP1796610A4 publication Critical patent/EP1796610A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)

EP05802679A 2004-09-29 2005-09-29 TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON DISEASE Withdrawn EP1796610A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US61376104P	2004-09-29	2004-09-29
US61376004P	2004-09-29	2004-09-29
PCT/US2005/035257 WO2006039532A2 (en)	2004-09-29	2005-09-29	Transdermal therapeutic system for parkinson’s disease

Publications (2)

Publication Number	Publication Date
EP1796610A2 EP1796610A2 (en)	2007-06-20
EP1796610A4 true EP1796610A4 (en)	2012-12-05

Family

ID=36143101

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP05802679A Withdrawn EP1796610A4 (en)	2004-09-29	2005-09-29	TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON DISEASE

Country Status (3)

Country	Link
EP (1)	EP1796610A4 (en)
JP (1)	JP2008514376A (en)
WO (1)	WO2006039532A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10041478A1 (en)	2000-08-24	2002-03-14	Sanol Arznei Schwarz Gmbh	New pharmaceutical composition
DE10361258A1 (en)	2003-12-24	2005-07-28	Schwarz Pharma Ag	Use of substituted 2-aminotetralins for the preventive treatment of Parkinson's disease
DE102004014841B4 (en)	2004-03-24	2006-07-06	Schwarz Pharma Ag	Use of rotigotine for the treatment and prevention of Parkinson-Plus syndrome
JPWO2015129527A1 (en)	2014-02-27	2017-03-30	株式会社メドレックス	Patch for treatment of neurodegenerative diseases containing pramipexole

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999049852A1 (en) *	1998-03-30	1999-10-07	Lts Lohmann Therapie-Systeme Ag	Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
EP1325742A1 (en) *	2001-05-08	2003-07-09	Schwarz Pharma Ag	Improved transdermal therapeutic system for the treatment of Parkinson's disease
EP1344522A1 (en) *	2001-05-08	2003-09-17	Schwarz Pharma Ag	Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
EP1386605A1 (en) *	2002-07-30	2004-02-04	Schwarz Pharma Ag	Improved transdermal delivery system for the administration of rotigotine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4885308A (en) *	1984-08-13	1989-12-05	Nelson Research & Development Co.	Method and compositions for treatment of parkinsonism syndrome in mammals
US5989586A (en) *	1992-10-05	1999-11-23	Cygnus, Inc.	Two-phase matrix for sustained release drug delivery device
US6024974A (en) *	1995-01-06	2000-02-15	Noven Pharmaceuticals, Inc.	Composition and methods for transdermal delivery of acid labile drugs
US6448303B1 (en) *	2000-12-29	2002-09-10	National Starch And Chemical Investment Holding Corporation	Hot melt adhesives for dermal application
DE10234673B4 (en) *	2002-07-30	2007-08-16	Schwarz Pharma Ag	Hot-melt TTS for the administration of rotigotine and process for its preparation, and use of rotigotine in the manufacture of a hot-melt TTS
DE10261696A1 (en) *	2002-12-30	2004-07-15	Schwarz Pharma Ag	Device for the transdermal administration of rotigotine base

2005
- 2005-09-29 EP EP05802679A patent/EP1796610A4/en not_active Withdrawn
- 2005-09-29 WO PCT/US2005/035257 patent/WO2006039532A2/en active Application Filing
- 2005-09-29 JP JP2007534813A patent/JP2008514376A/en active Pending

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999049852A1 (en) *	1998-03-30	1999-10-07	Lts Lohmann Therapie-Systeme Ag	Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof
EP1325742A1 (en) *	2001-05-08	2003-07-09	Schwarz Pharma Ag	Improved transdermal therapeutic system for the treatment of Parkinson's disease
EP1344522A1 (en) *	2001-05-08	2003-09-17	Schwarz Pharma Ag	Transdermal therapeutic system for Parkinson's disease inducing high plasma levels of rotigotine
EP1386605A1 (en) *	2002-07-30	2004-02-04	Schwarz Pharma Ag	Improved transdermal delivery system for the administration of rotigotine

Also Published As

Publication number	Publication date
JP2008514376A (en)	2008-05-08
EP1796610A2 (en)	2007-06-20
WO2006039532A2 (en)	2006-04-13
WO2006039532A3 (en)	2006-07-13

Publication	Publication Date	Title
IL250734A0 (en)	2017-04-30	Transdermal therapeutic system
DK3424932T3 (en)	2021-05-25	Bronophthalides for therapeutic use
DK3457135T3 (en)	2025-02-24	TREATMENT OPTIONS FOR FABRYS DISEASE
DK1879623T3 (en)	2012-12-17	GENTERAPY FOR BACKGROUND DISEASES
ATE524168T1 (en)	2011-09-15	TRANSDERMAL SYSTEM FOR VARENICLINE
EP1868459A4 (en)	2010-01-27	THERAPEUTIC SHOE
DK1844813T3 (en)	2010-02-15	Iontophoresis apparatus
DK2117521T3 (en)	2012-09-03	TRANSDERMAL ADMINISTRATION SYSTEMS INCLUDING BUPIVACAIN
DK2144905T3 (en)	2013-03-11	Therapeutic agents
DK2035369T3 (en)	2014-10-06	THERAPEUTIC
DK1993589T3 (en)	2014-01-06	Treatments for neurological diseases
AT500095B8 (en)	2007-02-15	TRANSDERMAL DELIVERY SYSTEM
DE602005005920D1 (en)	2008-05-21	Fastening device for wheelchair
BRPI0818598A2 (en)	2017-05-16	therapeutic agents - 802
DE112006001343A5 (en)	2008-03-06	patient support
FR2893278B1 (en)	2008-02-15	ALTERNATIVE LATERAL SUPPORT
ZA200809004B (en)	2009-10-28	Autodestructive transdermal therapeutic system
DK2119472T3 (en)	2014-10-13	Skin / hårbehandlingssystem
EP1796610A4 (en)	2012-12-05	TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON DISEASE
EP2140876A4 (en)	2011-08-03	THERAPEUTIC AGENT COMPRISING VASOHIBINE
ITVR20050112A1 (en)	2007-03-24	BED FOR MASSAGES
DE602005005655D1 (en)	2008-05-08	massage bed
DK1934388T3 (en)	2013-02-25	Process for drug development
DK1769359T3 (en)	2012-07-16	Publication data-verification system
ATA13282004A (en)	2005-08-15	MASSAGER

Legal Events

Date	Code	Title	Description
2007-05-18	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-06-20	17P	Request for examination filed	Effective date: 20070502
2007-06-20	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2007-06-20	AX	Request for extension of the european patent	Extension state: HR MK
2008-01-02	RAX	Requested extension states of the european patent have changed	Extension state: MK Payment date: 20070502 Extension state: HR Payment date: 20070502
2012-12-05	A4	Supplementary search report drawn up and despatched	Effective date: 20121105
2012-12-05	RIC1	Information provided on ipc code assigned before grant	Ipc: A61F 13/02 20060101AFI20121029BHEP Ipc: A61K 31/381 20060101ALI20121029BHEP Ipc: A61K 9/70 20060101ALI20121029BHEP Ipc: A61F 13/00 20060101ALI20121029BHEP
2013-11-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-12-04	18D	Application deemed to be withdrawn	Effective date: 20130604